A dinucleotide deletion in CD24 confers protection against autoimmune diseases
2007

CD24 Deletion Protects Against Autoimmune Diseases

Sample size: 275 publication Evidence: high

Author Information

Author(s): Wang Lizhong, Lin Shili, Rammohan Kottil W, Liu Zhenqiu, Liu Jin-qing, Liu Run-hua, Guinther Nikki, Lima Judy, Zhou Qunmin, Wang Tony, Zheng Xincheng, Birmingham Dan J, Rovin Brad H, Hebert Lee A, Wu Yeeling, Lynn D. Joanne, Cooke Glenn, Yu C. Yung, Zheng Pan, Liu Yang

Primary Institution: University of Michigan

Hypothesis

Does a dinucleotide deletion in the CD24 gene reduce the risk of multiple sclerosis and systemic lupus erythematosus?

Conclusion

The study found that a specific deletion in the CD24 gene significantly reduces the risk and progression of multiple sclerosis and systemic lupus erythematosus.

Supporting Evidence

  • The P1527del allele was associated with a significantly reduced risk of MS.
  • Patients with the P1527del allele showed delayed progression of MS.
  • The same polymorphism also conferred a reduced risk for systemic lupus erythematosus.

Takeaway

If you have a certain change in a gene called CD24, it can help protect you from getting some diseases where your body attacks itself, like multiple sclerosis and lupus.

Methodology

The study used case/control studies and family-based tests to analyze the association between CD24 polymorphisms and autoimmune diseases.

Participant Demographics

Caucasian participants with multiple sclerosis and systemic lupus erythematosus.

Statistical Information

P-Value

p = 0.002

Confidence Interval

0.34–0.82

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pgen.0030049

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication